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10 1. Introduction
11 1.1. TB in low incidence countries
12 Q4 Tuberculosis (TB) is a major global public health problem
13 affecting lower and middle income countries.1,2 TB continues to
14 present a signiﬁcant challenge in 33 low incidence countries
15 (deﬁned as 100 cases per million), which would include most of
16 Western Europe, the USA, Canada, Australia, and New Zealand.
17 Cases of TB are over-represented in socially and economically
18 marginalized populations in low incidence, high income countries
19 and, in particular, in migrant communities.1 More than 50% of TB
20 cases in low incidence countries occur amongst people born
21 outside of those countries; in some cases this ﬁgure increases to
22 90%.1 Migration from countries of high to low disease burden is
23 unlikely to decrease.
24In the UK in 2013, 70% of TB cases came from the 40% most
25economically deprived areas and 44% of TB cases did not have
26employment.3 In low incidence countries, TB is concentrated in
27groups often deﬁned as hard-to-reach, or underserved, and is
28characterized by complex health and social risks,4 for example
29homelessness, imprisonment, high rates of alcohol and substance
30misuse, HIV, a recent history of migration from countries with a
31high disease burden, and lack of entitlement to welfare. All of these
32factors can impact on access to health care and treatment
33outcomes and present particular challenges for services that
34may lack the necessary resources to outreach a service to
35vulnerable communities.
36In response to these unique challenges, in 2014 the World
37Health Organization (WHO), in collaboration with the European
38Respiratory Society (ERS),5 developed a framework of eight priority
39actions for the elimination of TB in countries with low incidence (or
40approaching low incidence): ensuring political commitment,
41addressing the needs of vulnerable and hard-to-reach groups
42and migrants (which includes actions to mitigate stigma), targeted
43screening for both active and latent disease in high-risk groups,
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S U M M A R Y
Tuberculosis (TB)-related stigma is an important social determinant of health. Research generally
highlights how stigma can have a considerable impact on individuals and communities, including delays
in seeking health care and adherence to treatment. There is scant research into the assessment of TB-
related stigma in low incidence countries. This study aimed to systematically map out the research into
stigma. A particular emphasis was placed on the methods employed to measure stigma, the conceptual
frameworks used to understand stigma, and whether structural factors were theorized. Twenty-two
studies were identiﬁed; the majority adopted a qualitative approach and aimed to assess knowledge,
attitudes, and beliefs about TB. Few studies included stigma as a substantive topic. Only one study aimed
to reduce stigma. A number of studies suggested that TB control measures and representations of
migrants in the media reporting of TB were implicated in the production of stigma. The paucity of
conceptual models and theories about how the social and structural determinants intersect with stigma
was apparent. Future interventions to reduce stigma, and measurements of effectiveness, would beneﬁt
from a stronger theoretical underpinning in relation to TB stigma and the intersection between the social
and structural determinants of health.
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44 improving case management, supporting global TB prevention
45 efforts, care and control, action on drug-resistant TB, and
46 investment in research.5 The framework clearly outlines the
47 challenge of decreasing TB incidence from >1000 cases per million
48 population to <100 cases per million by 2035. Out of the
49 33 countries, all but six have experienced an average rate of
50 decline of approximately 3% over a 12-year period. However future
51 projections suggest that no low incidence country will manage to
52 eliminate TB by 2035 and only one country would manage to
53 eliminate TB by 2050. The authors conclude that: ‘‘the task of
54 reaching TB elimination in the coming decades may thus seem
55 daunting, even in countries with the lowest incidence in the
56 world’’1 (page 4Q5 ).
57 In the last decade, we have witnessed a sea change in policy and
58 rhetoric underpinning TB care from one focused on a curative
59 model to one that, additionally, aims to tackle the social
60 determinants of disease that render people vulnerable to TB and
61 impact on their ability to sustain a course of treatment.6,7 The
62 social determinants of health (SDH) include the range of social,
63 political, economic, and environmental factors that determine the
64 health status of populations and hence risk of TB and treatment
65 outcomes. Despite the evidence that wealth inequalities are an
66 important predictor of TB rates in low incidence countries,8,9 some
67 argue that the social determinants of TB are overlooked given the
68 dominance of biomedical approaches,10which still emphasize case
69 detection, case management, and screening and surveillance,
70 particularly of migrant communities in TB control efforts. TB policy
71 may therefore reﬂect concerns about ‘border control and health
72 securitization’.11,12 The situation in low incidence countries,
73 therefore, is symptomatic of a global response to TB focused on
74 technical and biomedical solutions and the general failure of global
75 TB control efforts to address the underlying causes of TB.
76 1.2. Stigma as a social determinant of health
77 Stigma is a social determinant of health,13 found to be a major
78 barrier to accessing health care (hence resulting in diagnostic
79 delay) and the ability to manage illness and complete treat-
80 ment.14–16 Conceptualizations of stigma are most often borrowed
81 from Goffman (1963), who deﬁned stigma as ‘‘an attribute that is
82 deeply discrediting’’ (page 3), which ‘spoils’ a person’s social
83 identity or sense of selfQ6 . Goffman distinguished between people
84 who are ‘discredited’, whose stigma is visibly apparent or ‘known
85 about’, and the ‘discreditable’, those whose stigma is only
86 occasionally apparent as in the case of epilepsy.17 Scambler
87 differentiated between ‘felt’ stigma, or the fear of prejudice
88 perceived by individuals, and ‘enacted’ stigma, an overt act of
89 prejudice.18 He posited that felt stigma was ultimately more
90 socially and emotionally disruptive than enacted stigma because of
91 the psychological work (covering) an individual has to do to keep
92 the stigma hidden from others; for example: secrecy, avoidance,
93 and withdrawal from relationships,19,20 resulting in loneliness and
94 social isolation, or in some cases, engaging in risky behavior.21,22
95 Goffman used the term ‘courtesy stigma’ to describe the way
96 stigma extends to others by virtue of their association with the
97 stigmatized individual.
98 Others have differentiated between (1) internalized23 or self-
99 stigma24 (believing negative public stereotypes and translating
100 those negative perceptions to oneself), as exempliﬁed in people
101 with HIV,25 mental illness,26,27 and other concealable illnesses, (2)
102 anticipated stigma28 (fear of experiencing the negative effects of
103 stigmatization, akin to felt stigma), and (3) experienced stigma23,28
104 (discrimination, akin to enacted stigma).
105 Courtwright and Turner suggest stigmatization is different from
106 discrimination, as the former has more to do with shame, while the
107 latter involves exclusion.29 Here stigmatization is seen as ‘‘a
108complex process involving institutions, communities, and inter-
109and intrapersonal attitudes’’ (page 34). However, Deacon argues
110that stigma and discrimination, although related, are distinct
111entities, and calls for greater clarity on the relationship between
112the two, suggesting that stigma suffers from ‘‘conceptual inﬂation’’
113and ‘‘lack of analytical clarity’’.16
114These dimensions of stigma are not exhaustive or mutually
115exclusive when it comes to understanding stigma in relation to a
116social disease such as TB. Rather, they are inextricably linked to an
117individual’s social positioning.30–32 The prevalence of double or
118multiple stigmas is recorded among individuals affected by
119overlapping illnesses and social statuses. For example, multiple
120stigmas are documented along the lines of mental illness and
121race,33 mental illness and old age,31 and mental illness and
122cancer.34 Multiple stigmas are also identiﬁed among HIV-positive
123persons in the context of their minority ethnic status, race, sexual
124orientation,32,35 and/or gender.36 Studies with HIV patients show
125that multiple stigmas result in a greater social burden of illness, for
126which reason they may delay accessing medical attention and
127suffer worse adherence to prescribed treatments.32,33,35,36 In high
128HIV prevalence settings, TB is labelled as a marker for HIV, leading
129to distinct forms of double stigma that render stigmas associated
130with HIV to be transferred to those living with TB, and reinforce the
131stigmatization of HIV.30
132Contemporary scholars such as Link and Phelan32,37 Q7and Parker
133and Aggleton,38 suggest that the negative labelling of particular
134traits is socially created and used as a tool to assert dominance over
135people who are already marginalized within society on the basis of
136extant social inequalities (location), such as those related to race,
137class, religion, or gender. These later conceptualizations of stigma
138resonate with the social determinants of TB,39,40 and allow for
139stigma to be conceived of as a socially constructed phenomenon
140rather than an individualistic issue. Whether it be internalized, felt,
141or enacted, the construction of stigma is inevitably social.
142Technologies used to control TB, diagnostics, drugs, and
143guidelines have also been implicated in this social construction
144of stigma and can further reinforce stigma and stigmatizing
145practices. Innovations and technologies intersect with the setting
146they are introduced into and at times have unintended con-
147sequences; for instance HIV rapid tests that, due to their rapidity
148and ease of use, allow private doctors in India to test for HIV
149without the patient’s knowledge, further reinforcing the existing
150stigma that prevents patients agreeing to HIV testing.41 Similarly,
151patient treatment cards that identify patients as HIV- or TB-
152positive through their colour, physical spaces that identify HIV
153patients,42 or directly observed therapy (DOTS) treatment sche-
154dules that expect patients to attend a TB clinic in their community
155daily, can reinforce existing stigma. This suggests that TB control
156policies and research need to critically examine how to address the
157social determinants of TB, including the aspects of TB control that
158allow, perpetuate, or generate stigmatizing practices.
159These different deﬁnitions and understandings are important
160because, as Deacon16 (page 419) states: ‘‘Theories provide
161frameworks or models within which researchers can develop
162better research and intervention strategies’’. For if we cannot
163deﬁne stigma and understand how it operates, how can we
164measure stigma and devise strategies for reducing it?
165Generally, more research into interventions for reducing HIV
166stigma has been conducted and reviewed in systematic and global
167reviews43–45 than research into TB stigma reduction strategies, for
168which the ﬁrst systematic review in the ﬁeld is currently
169underway.46 Research into TB-related stigma has predominantly
170taken place in high incidence countries and, arguably, the evidence
171base is less well developed in low burden countries. For example, in
172one qualitative review of the stigma of TB, only four out of
17330 studies were from the USA and conducted before 2006; the
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174 remainder came from high incidence countries.19 Another review
175 reported on 99 studies globally: the majority were conducted in
176 Asia and the Paciﬁc Islands (33%), or were multiregional (17%) or
177 from Africa and the Middle East (28%). North America comprised
178 9%, with Latin/South America 8% and Europe/Russia 8%.29
179 However, results were synthesized and not differentiated accord-
180 ing to context or TB disease burden. Chang and Cataldo conducted a
181 systematic review of global cultural variations in knowledge,
182 attitudes, and health responses to TB stigma, where out of
183 83 studies, two were from the UK and eight were from the USA.47
184 Given stigma is increasingly associated with health inequalities,
185 the aim of this review is to contribute to debates about stigma as a
186 social determinant of health and, in particular, ways in which
187 stigma is deﬁned and measured, including any tools and
188 interventions that are effective in reducing stigma.48 It was with
189 this in mind that it was aimed to conduct a systematic mapping
190 review of research into TB-related stigma in low incidence
191 countries to map out recent research (the last 10 years), the main
192 characteristics, and identify any gaps.
193 2. Methods
194 A systematic mapping review of the literature was conducted to
195 identify research into TB stigma and associated interventions to
196 mitigate the impact of TB stigma.49 Mapping reviews aim to map
197 out and categorize research on a given topic with a view to
198 identifying evidence gaps and commission further reviews or
199 research as required. Mapping reviews do not appraise research for
200 quality, but rather describe and categorize the existing evidence
201 base.49 Additionally, in this review, it was aimed to explore: (a)
202 whether stigma was the main focus of the research, (b) the
203 theoretical underpinnings of the concept of stigma used in studies
204 and whether this was based on individual-level explanations or
205 factored in broader social determinants, as well as how stigma was
206 deﬁned, operationalized, and measured.
207 2.1. Inclusion and exclusion criteria
208 All articles from a low incidence country, deﬁned as 100 cases
209 per million, were included. However, because low incidence has
210 also been deﬁned as 20 cases per 100 000, and in order to enhance
211 the scope of the review, countries that were deﬁned as low
212 incidence using the broader deﬁnition were included to incorpo-
213 rate countries approaching low incidence, in line with the action
214 framework. Table 1 highlights all the countries as a result of the
215 more inclusive deﬁnition. Studies were also included if they
216 reported on primary research, including both qualitative and
217 quantitative studies or mixed methods; the focus was active or
218 latent TB infection (LTBI); interventions aimed to reduce stigma;
219 they aimed to explore or measure stigma including knowledge,
220 attitudes, beliefs, or experiences about TB, or health-seeking
221 practices or adherence. Only studies published in peer-reviewed
222 journals were included. The search was limited to articles
223 published between January 1, 2006 and January 1, 2016Q8 .
224 Articles were excluded if they were not written in the English
225 language, published in the grey literature, an opinion piece, a
226 conference abstract or dissertation, or a systematic review.
227 2.2. Keyword strategy
228 A keyword strategy was developed based on previous work
229 involving the lead author and an information scientist.50 Search
230 terms included medical subject heading (MeSH) or other
231 associated terms for TB and stigma. Two other researchers
232 reviewed the strategy (see Appendix A for an example). Additional
233 articles were obtained through further searches.
2342.3. Databases
235The following databases were searched: Centre for Reviews and
236Dissemination, CINAHL, Cochrane Central Register of Controlled
Table 1
TB in low incidence countries; estimated rate per 100 000Q22
population (2014)
High income countriesa TB rateb
Australia 6.4
Andorra 9.2
Antigua and Barbuda 7.6
Austria 7.8
Bahamas 12
Barbados 0.91
Belgium 9
Bermuda 0
British Virgin Islands 1.7
Canada 5.2
Cayman Islands 7
Chile 16
Cyprus 5.3
Czech Republic 4.6
Denmark 7.1
Finland 5.6
France 8.7
Germany 6.2
Greece 4.8
Hungary 12
Iceland 3.3
Ireland 7.4
Israel 5.8
Italy 6
Jamaica 4.7
Luxembourg 6.6
Malta 12
Monaco 2.2
Netherlands 5.8
New Zealand 7.4
Norway 8.1
Puerto Rico 1.4
San Marino 1.6
Slovakia 6.7
Slovenia 7.7
Sweden 7.5
Switzerland 6.3
Trinidad and Tobago 22
Turks and Caicos Islands 10
United Arab Emirates 1.6
United Kingdom 12
United States Virgin Islands -
USA 3.1
Upper middle income countriesa
Albania 19
American Samoa 7
Costa Rica 11
Cuba 9.4
Dominica 0.71
Grenada 1.3
Jordan 5.5
Lebanon 16
Libyan Arab Q2340
Lower middle income countriesa
Samoa 19
West Bank and Gaza Strip 5.8
Income no classiﬁcationa
Cook Islands 12
Jamahiriya -
Montserrat 0
Netherland Antilles -
Saints Kitts and Nevis 7.2
Saint Lucia 9.1
a World Bank list of economies (July 2016).
b Global Tuberculosis Report 2015. Key TB indicators for
individual countries and territories, WHO regions and the
world Q24. http://www.who.int/tb/publications/global_report/
gtbr15_annex04.pdf?ua=1.
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237 Trials, Cochrane Database of Systematic Reviews, MEDLINE,
238 PsychInfo, Embase, ERIC, SocINDEX, Social Policy & Practice, Global
239 Health.
240 2.4. Data extraction
241 The review and data extraction were informed by a critical
242 health psychology perspective (CHPP), which understands health
243 and illness behaviour within social, political, and cultural contexts
244 that not only inﬂuence health and illness, but systems of health
245 and social care.51,52 This approach also takes cognizance of the
246 SDH. The resulting framework was developed and studies coded
247 according to the year, country, sample characteristics, methods,
248 whether a deﬁnition of stigma was provided and the conceptual
249 framework used, whether it was an intervention study, how stigma
250 was measured, whether the focus included other diseases/co-
251 morbidities, e.g., HIV–TB stigma, and outcomes. The studies were
252 further coded according to the thematic content. All abstracts were
253 searched and where it was unclear whether the article should be
254 included, the full article was read. All articles were reviewed
255 independently by two researchers (G.M.C., A.I.) and the lead
256 researcher reviewed all articles.
257 3. Results
258 The abstracts of 204 citations were identiﬁed from the search
259 and an additional 14 from other sources (including seven articles
260 obtained when the search was re-run to include the names of
261 additional low incidence countries in line with the inclusive
262 deﬁnition). Fifty-three duplicates were removed leaving
263165 abstracts, and 134 of these were excluded. Of the remaining
26431 articles, nine were excluded at full review, leaving 22 studies in
265total. Figure 1 provides the reasons for the exclusions.
2663.1. Which low incidence country has conducted research into TB with
267relevance to stigma?
268Twenty-two studies were included in the review. The majority
269of studies (n = 10) were conducted in Canada/USA, followed by the
270UK (n = 7), Europe (n = 2), and Australia/New Zealand (n = 3). There
271was only one intervention study (health education), which was
272conducted in Australia (Sheikh and MacIntyre53 Q9), although TB was
273not the main focus and neither was stigma. There were no studies
274from lower/middle income countries represented in this review.
275Table 2 characterizes the studies in more detail.
2763.2. Which type of community was the focus of the research?
277Most of the research studies focused on migrant communi-
278ties,54 including communities from broadly Spanish-speaking
279South American and Caribbean countries,55–58 Sub-Saharan Afri-
280can refugees,53migrants or refugees from Somalia or Ethiopia,59–61
281Chinese migrants,62 African communities/migrants,63 homeless
282populations,58,64,65 migrant and refugee learners,66 and a mixed
283population of migrants;67,68 one study was performed in an
284indigenous community – the Inuit.69 Only one study surveyed the
285views of the general population in the USA.34,70 Q10Three textual
286studies aimed to analyse how migrants were represented in the
287media in relation to reports about TB.11,71,72 The focus on different
288migrant communities reﬂects patterns of migration in different
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Figure 1. Flow diagram.
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Table 2
Included studies
No. Country Authors Methods Participants and other
details
Conceptual framework Selected ﬁndings
1 USA/Canada Colson et al., 2014
[54]
Population-based cross-
sectional survey;
structured interviews
administered face-to-face
1475 participants; born
outside USA/Canada
K-A-B Improved health education for
people born outside UKQ25
Measures to reduce stigma
needed
2 Australia Sheikh and
MacIntyre, 2009
[53]
Intervention study;
structured questionnaire
developed in focus groups
administered face-to-face
34 Sub-Saharan African
refugees and 12 non-
African refugee parents
K-A-B Targeted promotion to refugee
parents is effective in changing
K-A-B about infectious diseases
3 USA Lurie et al., 2012
[55]
Qualitative research 5 bilingual focus groups
including Mexican, Puerto
Rican, Venezuelan,
Ecuadoran, Haitian
American, and indigenous
persons from Latin
America; interviews with
agency leaders and staff
K-A-B Local agencies can serve as
informed liaisons to improve the
health of newly arrived
immigrants
Stigmatized through public
health emphasis on elevated risk
4 USA Wieland et al.,
201266Q26
Community-based
participatory research
10 focus groups;
83 people in total;
immigrant and refugee
learners and staff in an
adult education centre
Health belief model Perception of TB included
secrecy, shame, fear and
isolation
Adult education centres with
large immigrant and refugee
populations are good venues for
TB prevention
5 Australia Horner, 2015 [71] Qualitative research;
critical textual analysis;
interviews; analysis of
print media
19 migrants with TB in
Canada, HCP
Discourse theory Need to prioritize settlement
support and health care rather
than disease through migrant
screening, which reinforces
stigma
6 Canada Gao et al., 2015 [62] Qualitative research;
mixed methods cross-
sectional patient survey,
focus group
912 survey respondents
and 2 focus groups;
Chinese immigrants
K-A-B Need to raise awareness of LTBI
and reduce LTBI-related stigma
Cost of treatment a signiﬁcant
barrier
7 Canada Reitmanova and
Gustafson, 2012
[11]
Qualitative research;
textual analysis of print
media
273 news articles,
editorial and letters
analysis; of how are
migrants represented in
media
Discourse theory TB control policies focus on
screening and surveillance
Media racializes and represents
migrants as a health threat
8 New Zealand Lawrence et al.,
2008 [72]
Qualitative research,
newspaper reports as a
case study; textual
analysis
120 media
representations of TB
Discourse theory Media fails to report on links
between the SDH and TB
Migrants stigmatized
Attention to the cultural and
political context needed when
reporting TB
9 USA/Haiti Coreil et al., 2010
[56]
Mixed method, cultural
epidemiology and
ethnography using EMIC
182 in-depth interviews
and 12 focus group
Haitians living in South
Florida; Haitians residing
in Leogane Commune,
Haiti
Structural forces in the
production of TB-
related stigma
perceived and
anticipated stigma
Discussions of ﬁndings focused
on the social production of
perceived and anticipated
stigma as inﬂuenced by politics,
economics, institutional polices
and health service delivery
structures
Findings demonstrate value of
transnational framework
10 USA Joseph et al., 2008
[57]
Ethnographic research 50 interviews with
Mexican-born persons
living in Atlanta/Denver in
the USA
Socio-cultural aspects
of TB reﬂected in
stigma scale
Concern about stigma varied,
depending on TB status
Anticipated stigma by those with
no history of TB was greater than
the actual stigma reported by
people who had TB disease
11 UK Nnoaham et al.,
2006 [63]
Qualitative interview
study
16 people self-identiﬁed
as African living in the UK
attending a clinic for TB
treatment, London, UK
Enacted or felt stigma
using Kleinman’s
explanatory model of
illness
Despite reports of felt stigma,
denial reduced with good coping
strategies
Reports of good adherence
suggest stigma can be mitigated
12 USA West et al., 2008
[58]
Qualitative research, focus
groups
11 focus groups;
52 participants; Spanish-
speaking immigrants,
homeless shelter
residents, and persons
attending a drug/alcohol
rehabilitation centre
K-A-B Participants projecting disease
onto other social groups
perceived as less desirable is also
evidence of stigma
13 UK Gerrish et al., 2013
[60]
A focused ethnography
with individual
interviews
14 Somali refugees who
had received treatment
for TB in the UK; 18 health
care practitioners
Socio-cultural aspects
of TB
Although patients reported felt
and enacted stigma, they
reported good adherence to
treatment
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289 countries. Three studies involved community leaders and their
290 views on how TB and stigma were perceived within their own
291 communities.55,59,68
292 3.3. What research methods were used?
293 The majority of studies (18/22) could best be described as
294 qualitative, involving interviews and/or focus groups; three of
295these 18 studies adopted a textual analysis of print media and ﬁve
296adopted an ethnographic approach. Two out of the total 22 studies
297involved population-based surveys and there was one mixed
298methods study involving a patient survey and focus group. Two
299studies involved a comparator group. Coreil et al. compared the
300views of Haitian migrants living in Florida with Haitians residing in
301Haiti.56 Sheik and MacIntyre compared 34 Sub-Saharan African
302refugee parents with 12 non-African refugee parents.53
Table 2 (Continued )
No. Country Authors Methods Participants and other
details
Conceptual framework Selected ﬁndings
14 UK Craig and Zumla,
2015 [64]
Qualitative interview
study
7/17 participants were
African migrants; the
majority were homeless
and had complex medical
and social needs,
including drug and
alcohol use or
immigration issues
Social context of
adherence; critical
health, psychology/
SDH
Reported on an example of felt
stigma
TB used as an excuse to shun and
evict a person because of dislike
Others reported social
distancing, sympathy,
indifference and acceptance
15 UK Brewin et al., 2006
[67]
Qualitative interview
study
53 adult immigrants None reported Stigma not mentioned
Acceptability of screening high
in migrant communities, seen as
a socially responsible activity
The view of screening unfairly
targeted at migrants not
supported
16 Norway Sagbakken et al.,
2010 [74]
Qualitative interview
study
22 patients from Somalia
and Ethiopia; the duration
of stay in Norway varied
from 6 months to 16 years
None reported Stigma not mentioned, but there
was a suggestion that perceived
negative attitudes of health care
staff toward migrants could
result in delay
17 UK Gerrish et al., 2012
[59]
A focused ethnography,
interviews, and focus
group
48 individual interviews;
8 focus groups, involving
56 people; community
leaders from Somali
organizations; members
of the wider Somali
community and patients
who were receiving or had
recently completed TB
treatment
Socio-cultural
meanings
Authors developed model of
stigma based on beliefs,
attitudes, experiences of
anticipated or actual stigma/felt
andQ27 enacted are also used
strategies employed to avoid
stigma
18 USA Marks et al., 2008
[70]
National health interview
survey
190 350 unweighted and
209 560 379 weighted
respondents; civilian,
non-institutionalized
household residents from
2000 to 2005
K-A-B Poor knowledge of TB
transmission and curability in
general population
Experience of shame more likely
in marginalized groups
19 UK Seedat et al., 2014
[68]
Qualitative interview
study
20 interviews with
community leaders
representing new
migrants groups
None reported Screening acceptable
Barriers include disease-related
stigma in communities and
perceptions that services are non
migrant friendly – not accessible
to migrants
20 Sweden Kulane et al., 2010
[61]
Qualitative research 5 focus groups with
34 adult women and men
from the Somali
community living in
Stockholm
None reported Use of interpreters a concern if
they came from the community
Contact tracing associated with a
fear of deportation
21 UK Craig et al., 2014
[65]
Qualitative interview
study
7/17 were African
migrants; the majority
were homeless and had
complex medical and
social needs, including
drug or alcohol use or
immigration issues
Critical health
psychology/SDH
Fear of drug withdrawal in PWID
– major barrier to health seeking
Stigma not reported as people
did not associate symptoms with
TB
22 Canada Møller, 2010 [69] Qualitative ethnographic
research, interviews/
observations
29 Inuit; 7 interviews of
health care professionals
None reported Participants discussed illness
experiences in the context of
oppression, prejudice, and
racism
Examples of discrimination
within and outside the health
care system impacted on the
experiences of TB
K-A-B, knowledge, attitudes, beliefs; TB, tuberculosis; HCP, health care professionals; LTBI, latent TB infection; SDH, social determinants of health; EMIC,Q28 ; PWID, people who
inject drugs.
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303 3.4. Was stigma the main focus for the research?
304 Few studies set out to research TB-related stigma as the main
305 focus,56,60,63 and only one study featured the word ‘stigma’ in the
306 title.56 Rather stigma emerged in many studies about knowledge,
307 attitudes, and beliefs (K-A-B) about TB, or studies on the socio-
308 cultural understandings or experiences of affected communities.
309 This is not surprising given that qualitative research aims to allow
310 themes to emerge from the data. Other studies included questions
311 on stigma in relation to the broader aims of capturing knowledge
312 and beliefs about TB or infectious diseases more generally.
313 Two studies focused on a range of infectious diseases in
314 addition to TB, including a study that aimed to raise awareness of
315 infectious diseases in refugee communities53 and an interview
316 study with community leaders exploring the acceptability of
317 screening for infectious diseases in recent migrants.68 In the latter
318 study, although screening was reported to be acceptable, ‘disease-
319 related stigma’ was found to be a barrier. The study by Brewin et al.
320 also focused on the acceptability of TB screening in migrant
321 populations in the UK, but did not anticipate or report stigma in
322 the ﬁndings.67 Rather, screening was reported as a socially
323 responsible activity with a high degree of acceptability in migrant
324 communities. Craig and colleagues suggested that stigma was not
325 reported as a barrier to accessing health care, as patients with
326 complex health and social needs generally did not attribute their
327 symptoms to TB, rather they normalized their symptoms in the
328 context of their everyday lives.65 Only one study focused on LTBI
329 in Canada; the authors argued for greater awareness of LTBI and
330 measures to reduce LTBI-related stigma in Chinese migrant
331 communities.62
332 3.5. How was stigma measured?
333 Where studies set out to explore TB-related stigma, the
334 majority used structured questions to determine attitudes and
335 beliefs about TB and hence stigma (see Table 3). Colson et al., in a
336 cross-sectional study ascertaining the attitudes and beliefs of
337 people diagnosed with TB and born outside the USA/Canada, used
338 structured questionnaires administered in face-to-face inter-
339 views.54Of the 14 attitudinal items, three questions were designed
340 to measure stigma, including differential treatment by others,
341 concern about others knowing a person’s TB status, being found
342 out, and concerns about deportation. A further question on
343 disclosure was included under group norms, rather than stigma,
344 but could be used as a proxy for stigma. West et al. used a
345 standardized list of questions to guide focus group discussions and
346 asked participants what they thought about people with TB.58
347 Sheik and MacIntyre piloted a questionnaire to evaluate a change
348 in attitudes, knowledge, and health beliefs before and after an
349 educational intervention in a structured questionnaire adminis-
350 tered face-to-face and asked the participants if they would be
351 ashamed if a family member had TB or whether TB was caused by
352 sin.53 Marks and colleagues, in a national health survey in the USA
353 that included seven questions on TB, one of which addressed
354 stigma, asked whether the respondent, or family members, would
355 feel shame and embarrassment if diagnosed with TB.70 In the study
356 by Coreil et al., the researchers adapted a semi-structured
357 instrument to include a stigma scale with 22 core items for the
358 Haitian sample and 24 for the Florida sample.56 The scale explored
359 internal perceptions and emotions (2 items), disclosure (6 items),
360 external perceptions (4 items), external actions (6 items), and
361 courtesy stigma (3 items), as well as two items that related
362 speciﬁcally to Haitian identity as migrants in Florida, and thereby
363 attempted to capture the intersection of TB stigma with migrant
364 identity. The internal consistency of the scale was reported to be
365 good (Cronbach’s alpha >0.80)
3663.6. Conceptual frameworks
367As there were few studies that aimed to research stigma, the
368range of conceptual models theorizing stigma was limited. The
369study by Coreil et al. drew on perceived and anticipated stigma;56
370Nnoaham et al. drew on felt and enacted stigma.63 Coreil focused
371on the social production of perceived and anticipated stigma
372informed by the political and economic context, institutional
373policies, and health service delivery structures. Disease-related
374stigma and community stigma were also reported.68
375Two studies drew on the concepts of felt and enacted stigma to
376illustrate their ﬁndings.59,64 Gerrish et al. devised a model on the
377meaning and consequences of TB, including ways in which
378historical contexts, cultural norms, and individual experiences
379inﬂuence ideas about the causes, transmission, and treatment of
380TB, which then inﬂuenced attitudes and translated into anticipated
381stigma (felt stigma – fear of discrimination, a sense of shame and
382lack of self-worth) or enacted stigma (experience of discrimina-
383tion, social isolation, and social exclusion leading to feelings of low
384self-esteem and risk of depression, with the resulting coping
385strategies of withdrawal, concealment, or open/partial disclo-
386sure).59
387Excluding the three research studies that analysed textual print
388media, seven of 19 studies adopted a K-A-B approach to TB/
389infectious diseases (see Table 1), including one study that was
390explicitly premised on the health belief model (HBM) as a lens to
391understand the views of participants.66 Four studies drew on the
392socio-cultural meanings participants ascribed to TB, three studies
393explicitly adopted a structural/social determinants approach, and
394four studies did not report the use of a conceptual framework. One
395study related the experiences of indigenous people to a history of
396colonialism.69
397The predominance of the K-A-B studies is not surprising given
398the dominance of social cognition models (most commonly
399referred to as the health belief model, HBM) in the literature on
400health-seeking practices. The HBM was initially developed to
Table 3
Range of questions/scales used in the studies to measure stigma
Colson et al., 2014 [54]
Stigma
Do people who know that you have TB treat you differently?
Are you concerned that others may ﬁnd out that you have TB?
When you went for TB treatment, were you afraid you might be sent back
to the country you came from?
Group norms
Have you told people close to you that you have TB?
Marks et al., 2008 [70]
If you or a member of your family were diagnosed with TB, would you feel
ashamed or embarrassed?
Sheik and MacIntyre, 2009 [53]
Would not be ashamed if family member had TB
Sins can cause TB
West et al., 2008 [58]
What would you think about a person with TB?
Coreil et al., 2010 [56]
Internal perceptions and emotions
e.g., Would Jean think less of himself because he has TB?
Disclosure
e.g., Do you think Jean would discuss this problem with family members/
close friends/neighbours?
External perceptions
e.g., Would people assume he [Jean] has HIV?
External actions
e.g., Do you think people might avoid Jean because of his actions?
Courtesy stigma
e.g., Would contact with Jean have bad effects on others around him even
after he is treated?
Haitian identity
e.g., Is it more embarrassing for Jean to have TB because he is Haitian than
it would be for other people in Florida?
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401 understand the reasons for the failure of a free, preventative TB
402 screening programme in the USA in the 1950s.73 Social cognition
403 models posit a (linear and possibly incremental) relationship
404 between knowledge, beliefs, and access to health care, but have
405 been criticized for their rational actor approach, which over-
406 states individual agency.39 The role of structures including the
407 wider socio-economic and programmatic barriers are therefore
408 often under-theorized within these models. In the main, K-A-B
409 studies recommend increasing awareness of disease through an
410 education-through-information approach levelled at the indi-
411 vidual or community. Additionally some K-A-B studies also
412 acknowledge programmatic barriers, for example, the cost of
413 treatment.62
414 3.7. Stigma and programmatic barriers
415 A number of studies brought into relief the programmatic
416 barriers to health-seeking practices and illness management. Craig
417 and Zumla, for example, reported on the zero tolerance policies of a
418 hospital on the use of drugs and alcohol as a barrier to accessing
419 care.64 The perception that methadone was under-prescribed for
420 those patients who used drugs, and the subsequent fear of
421 experiencing withdrawal syndrome, was also a concern. Studies on
422 TB and infectious disease screening, including HIV, have reported
423 high levels of acceptability amongst migrant communities,67 but
424 choice of place of screening was considered crucial and some
425 screening facilities were not viewed as accessible or migrant-
426 friendly.68 Fear of deportation as a result of contact tracing has also
427 been reported in a Swedish study involving the Somali communi-
428 ty.61 One study in Norway suggested that health care delay may be
429 due to the negative attitudes of staff. Contact tracing was
430 associated with the threat of deportation, and the use of
431 interpreters was of concern if they came from the same
432 community.74 These studies suggest that stigma per se may not
433 be a barrier to accessing health care, but rather policies that can be
434 discriminatory and service delivery models that are not patient-
435 centred and that may also reinforce stigma. Interventions at the
436 programmatic level would be needed in these examples.
437 3.8. Stigma and structural determinants
438 There were studies that analysed the wider structural causes of
439 stigma; for example, the study by Coreil et al. demonstrated the
440 intersection of stigma, discrimination, and identity as a migrant in
441 a sample of Haitians in Florida compared with non-migrant
442 Haitians in Haiti.56 The study highlighted how TB policies, such as
443 detention, intersected with the marginalized status of Haitians
444 living in the USA and their migrant identity in ways that were
445 speciﬁc to the USA context compared with non-migrant Haitians
446 living in Haiti. In one study of the Inuit community, participants
447 discussed their experiences of TB in the context of colonialism,
448 oppression, prejudice, and racism.69 They recounted examples of
449 inhumane treatment historically in relation to TB control polices.
450 Examples of discrimination within and outside of the health care
451 sector therefore impacted on their experiences of TB. The author
452 concluded that decolonizing measures were necessary to address
453 the high incidence of TB.
454 The three studies with a focus on textual analyses of print media
455 and newspaper articles used discourse theory to explore repre-
456 sentations of TB and migrants in Australia,71 Canada,11 and New
457 Zealand. The authors argue that media reporting serves to
458 stigmatize migrant communities by racializing TB and construct-
459 ing migrants as the health threat; the focus on migrant screening
460 and surveillance also serves to reinforce stigma by suggesting the
461 locus of the problem resides within migrants, and not the social
462 determinants of disease.
463Marks et al. identiﬁed poor knowledge of TB transmission and
464curability among a representative sample of the general popula-
465tion in the USA, suggesting a lack of awareness is not solely an issue
466for those communities most affected.70 A small percentage (2%)
467reported feeling ashamed or embarrassed if they had a family
468member with TB, and this relationship increased if the respondent
469was homeless or a prisoner (2.2-times as likely), or born outside
470the USA (1.5-times as likely). Similar patterns were found with
471ethnic status (black) and education (low), reﬂecting the intersec-
472tion between stigma and social positioning, particularly amongst
473marginalized groups, but in general the intersection of the SDH
474was under-theorized. These complex intersections present chal-
475lenges for stigma reduction interventions in terms of how they can
476be tailored to speciﬁc groups and contexts.
4774. Discussion
478Stigma research in low incidence countries is mainly conducted
479in migrant populations because these groups are over-represented
480in the TB statistics and comprise the majority of communities
481affected by TB. A number of studies included interviews with
482community leaders who represented the views of those commu-
483nities. Although valued as an important source of expertise within
484those studies, this does raise issues about who represents the
485voices of communities and which sectors of the community are
486included or excluded in these accounts. Few studies in this review
487addressed stigma as a substantive topic, rather stigma emerged as
488a theme within studies that aimed to explore knowledge, beliefs,
489and health-seeking practices more generally. This contrasts with
490research in the HIV ﬁeld,75 where the evidence base is more
491extensive.
492There was only one study that reported on LTBI and LTBI-
493related stigma, although it was unclear whether LTBI stigma was
494qualitatively different to TB stigma.62 No studies focused on the
495relationship between HIV and TB stigma and no studies focused on
496stigma in relation to drug-resistant TB. This may be because the
497number of people who experience HIV–TB co-infection or drug-
498resistant disease is relatively small in low incidence countries
499compared to high disease burden contexts. The difﬁculty of
500accessing the views of these groups and indeed the impact of
501stigma and willingness to participate in research may also be
502reasons. Research in high disease burden countries suggests
503patients with multidrug-resistant and extensively drug-resistant
504TB may experience particular forms of stigmatization on account of
505their incurable and contagious state.76 No research focused on TB-
506related stigma in health care workers and no studies attended to
507gender as a social determinant.
508Both quantitative and qualitative research was used and only
509one study reported on the use of a validated stigma scale to
510measure stigma.56 The dearth of intervention studies is worthy of
511comment. Courtwright and Turner, in their systematic review of
512the global TB literature, similarly concluded that interventions to
513reduce TB stigma and analyses of how they impact on diagnostic
514delay and treatment adherence are few.29 Yet no studies have
515investigated whether and how TB stigma reduction impacts on TB
516morbidity and mortality.29,43,46 While some interventions, such as
517TB clubs, have been reported to decrease stigma and improve
518adherence, other interventions involving an educational compo-
519nent have not.29
520Moreover intervention studies would clearly beneﬁt from a
521stronger theoretical underpinning in relation to the social
522determinants. K-A-B studies, which assume improving knowledge
523will result in health-seeking, premised on an information-through-
524education model, fail to take into account the structural barriers
525that impact on health-seeking practices and ways in which social
526positioning intersect with racism and discrimination for example.
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527 Avoidance of health care may be less to do with stigma than fear of
528 discrimination based on other factors. The difﬁculty for any
529 intervention study will be to identify, theorize, and take action on
530 those very structural factors. Lessons may be learned from the HIV
531 ﬁeld, where socio-ecological models have been applied routinely
532 to interventions to tackle the multiple drivers of stigma in people
533 with HIV.43,77,78 Attention and action on HIV stigma have also
534 stemmed from the creation of a distinct, indeed exceptional, HIV
535 community as a result of the more acute levels of discrimination
536 experienced by those affected in the early stages of the global
537 epidemic. The very forces that suppressed the rights of people with
538 HIV led to mass movements of global resistance, world over, to
539 quell systematic actions on the parts of individuals, systems, and
540 governments, that could compound their stigmatization.79,80 This
541 is in sharp contrast to responses for TB, where collective efforts to
542 empower communities most affected by TB have struggled to
543 gather commensurate momentum.
544 In line with other research, TB control programmes and
545 practices were reported to (inadvertently) contribute to, or cause,
546 stigma. In one systematic review of qualitative research on TB in
547 migrant populations, the authors reported that TB-related stigma
548 has been prominent because of the assumed impact on TB
549 screening and treatments ‘‘rather than a consequence of these
550 programmes’’ (page 9).81Authors have cautioned about the way TB
551 is represented in research or the popular press as a disease of
552 migrants or ‘‘foreign born and hence the outsiders’’ and a ‘‘non-
553 native threat’’82 (page 129Q11 ). This raises ethical issues about the way
554 communities are represented in research and in TB control
555 programmes.83–85
556 Few studies embraced a SDH framework to render legible the
557 experiences of participants and there was a tendency to homoge-
558 nize experiences of a diverse range of migrants, rather than
559 theorize difference according to social positioning (e.g., gender).
560 Despite a global consensus on the relevance of the social
561 determinants of TB and the relevance and recognition of a SDH
562 framework across many research disciplines, including the global
563 policy world, they are often not effectively translated into policy
564 and action. This is partly because SDH, such as stigma, tend to be
565 conceptualized as mere individual barriers to health interventions
566 rather than structural factors (as evidenced by the number of
567 studies conceptualizing TB stigma within an individualistic K-A-B
568 framework), and partly because of the limited understanding of the
569 exact relationship between SDH and health (as evidenced by the
570 overall limited number of comprehensive in-depth case studies of
571 stigma). Effective policy and action, taking into account stigma as a
572 SDH, thus requires extensive and in-depth case studies to allow a
573 careful and comprehensive understanding of the different
574 elements and how they interact at local, national, and global
575 levels.48
576 4.1. Questions and challenges for future research
577 Given TB predominantly affects migrant communities or
578 newcomers in low incidence countries, further research into
579 effective strategies for reducing TB stigma in migrant and other
580 populations within a SDH framework is warranted. Although
581 lessons may be learned from evidence based on ﬁndings in low and
582 middle income countries, these will need to be translated and
583 adapted to local country contexts. More research is needed to
584 determine differences in experience, both within and between
585 migrant communities and in relation to LTBI and active disease, but
586 also how people’s experiences are inﬂuenced by the wider social
587 and structural determinants.
588 A structural approach to the causes of stigma inevitably raises
589 more complex theorizations of the intersections between stigma,
590 other stigmatizing illnesses (HIV, hepatitis), stigmatized identities
591(sex worker, drug user), and social positioning (e.g., migrant,
592gender). There are gaps in this regard in low incidence countries.
593The difﬁculty of measuring the effectiveness of TB stigma
594reduction strategies that take into account the complex ways in
595which these social determinants intersect should not be under-
596estimated,86 particularly in marginalized communities. Chang and
597Cataldo argue that cultural variations need to be factored into
598interventions aimed at reducing stigma and improving treatment
599adherence, which, given the diversity of communities affected,
600presents its own challenges.47 Møller cautions that culturally
601appropriate health care may be difﬁcult to deliver to indigenous
602communities, not least because of the colonial models of health
603professional education (page 42).69 Indeed we might ask how
604different identities and social positioning interact with the very
605interventions to tackle stigma and the implications for engage-
606ment with such interventions.
607The need to translate measures and tools into the various
608community languages, given migrant populations are not homo-
609geneous, will also present cost and logistical challenges.65 For
610example in London, UK, approximately 22% of people do not speak
611English as their ﬁrst language, and in some London boroughs, over
612100 different languages are spoken, a pattern common in many
613major cities, suggesting a role for bilingual researchers. Process
614evaluations and sophisticated qualitative methods, including
615ethnographic approaches and case studies, will be needed to
616inform the development of future interventions and to measure
617outcomes, in addition to providing rich contextual detail to better
618understand how complex interventions work.87 Finally the major
619challenge for TB programmes and researchers will be how to
620research and report on the experiences of vulnerable communities
621in ways that do not reinforce stigma. This is particularly difﬁcult
622when interventions, and hence research, are targeted at affected
623communities in low incidence countries rather than the general
624population.
6254.2. Conclusions
626There is scant research into the assessment of TB stigma in TB in
627low incidence settings. As stated by Macq et al. ‘‘It is striking to see
628that stigma is at the center of global strategies to ﬁght AIDS and it is
629so little present in the international priorities of TB control’’ (page
630351).75
631Priority action 7 of the WHO and ERS framework for the
632elimination of TB in low incidence countries recognizes the need to
633invest in research and new tools.5 There is ample evidence to
634suggest that TB is represented and experienced as a stigmatizing
635disease by many different communities in low burden settings,
636either due to illness or particular practices of TB control measures.
637There is much less research on how the social determinants
638intersect with stigma and interventions to reduce stigma,
639including what such interventions should look like and how
640reductions in stigma can be measured. The framework may
641provide a driver for such research. Finally approaching stigma as a
642problem requiring a technical ﬁx by the health sector, without
643addressing the inequities that place communities at risk of disease
644and poor health outcomes, within and between countries, will
645have little impact without accompanying global political solu-
646tions.88
6474.3. Limitations
648It is possible that some research was missed, as not all articles
649were read in full if stigma was not mentioned in the abstract or if
650the abstract did not indicate the study was relevant for full article
651review. Given much research focused on knowledge, attitudes, and
652beliefs, in which stigma emerges as a theme rather than an extant
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653 focus, this only adds to the contention that, unlike HIV stigma, TB
654 stigma is rarely researched as a topic in its own right in low burden
655 countries, despite being an important SDH. This may reﬂect the
656 dominance of biomedical research. Some studies were not
657 included because they fell outside the period of study for the
658 review (i.e., before 2006). However given that the populations
659 affected by TB, TB as a disease, and stigma are dynamic, social
660 phenomena with manifestations contingent upon time, place,
661 space, social positioning, and geo-political factors, experiences and
662 solutions derived from research more than 10 years ago may need
663 to be reappraised in the contemporary situation, including their
664 relevance to low burden settings. The research studies were not
665 appraised for quality; some have argued that mapping research
666 studies without addressing quality may be of limited value.
667 However the aim was to map the nature of research into TB stigma
668 (including stigma reduction interventions) in low incidence
669 countries and the conceptual frameworks adopted, to provide a
670 better understanding of how stigma operates and intersects with
671 other social statuses or positioning. Few studies set out to address
672 these aims and therefore achieved this ‘gold standard’ in this
673 review.
674 Funding: None.
675 Conflict of interest: None.
676 Appendix A
677 Example of search terms used in relation to stigma in CINHAL
679 (‘‘Stigma’’) OR (MH ‘‘Stereotyping’’) OR (MH ‘‘Social Attitudes’’) OR
680 (MH ‘‘Social Norms’’) OR (MH ‘‘Social Behavior’’) OR (MH ‘‘Social Identity’’)
681 OR (MH ‘‘Social Conformity’’) OR (MH ‘‘Social Inclusion’’) OR (MH ‘‘Social
682 Isolation’’) OR (MH ‘‘Social Alienation’’) OR (MH ‘‘Social Participation’’) OR
683 (MH ‘‘Social Values’’) OR (MH ‘‘Vulnerability’’)
684 AB discriminat* OR AB prejudice* OR AB ‘‘social determinants’’ N3 health
685 OR AB ‘‘social* exclus*’’ OR AB marginali#* OR AB soci* N3 reject* OR AB
686 scapegoat*
687 AB stigma OR AB stereotyp* OR AB ‘‘social attitudes’’ OR AB ‘‘social norms’’
688 OR AB ‘‘social behavio#r’’ OR AB ‘‘social identit*’’ OR AB ‘‘social conformity’’
689 OR AB ‘‘social* inclusi*’’ OR AB ‘‘social* isolat*’’ OR AB ‘‘social alienat*’’
690 OR AB ‘‘social participation’’ OR AB ‘‘social values’’
691 (MH ‘‘Social Determinants of Health’’) OR (MH ‘‘Health Status Disparities’’)
692 (MH ‘‘Prejudice’’) OR (MH ‘‘Scapegoating’’) OR (MH ‘‘Social Conformity’’) OR
693 (MH ‘‘Social Desirability’’)
694 (MH ‘‘Social Norms’’) OR (MH ‘‘Social Isolation’’) OR (MH ‘‘Social Alienation’’)
695 (MH ‘‘Social Stigma’’) OR (MH ‘‘Stereotyping’’) OR (MH ‘‘Social
696 Marginalization’’) OR (MH ‘‘Social Isolation’’) OR (MH ‘‘Social Discrimination’’)
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